Your search history is turned on.
Date: April 30, 2024 Jurisdictions: Alberta, British Columbia
AVC2024-04-30NR-YE2023Result-FINAL AVRICORE HEALTH CORPORATE UPDATE AND AUDITED RESULTS FOR 2023 VANCOUVER, BRITISH COLUMBIA, April 30, 2024 AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or AVCR) is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross profit increased by ...
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia
_ Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Kiki Smith, CFO of Avricore Health Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference i...
_ Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Hector Bremner, CEO of Avricore Health Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by referenc...
Date: April 29, 2024 Jurisdictions: Alberta
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Avricore Health Inc. - MD&A Avricore Health Inc. Management's Discussion & Analysis For the year ended December 31, 2023 Avricore Health Inc. Management's Discussion and Analysis as of April 29, 2024 2 | P a g e This Management Discussion and Analysis ("MD&A") of Avricore Health Inc. ("AVRICORE", the "Company"...
Avricore Health Inc. - FS Avricore Health Inc. Consolidated Financial Statements For the Years Ended December 31, 2023, 2022 and 2021 (Expressed in Canadian Dollars) REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and the Board of Directors of Avricore Health Inc. Opinion on the Financial Statements ...
Date: April 16, 2024 Jurisdictions: Alberta, British Columbia
MOSAM CAPITAL CORP ________________________________________________________________________ Suite 1120 - 789 West Pender Street, Vancouver, BC V6C 1H2 Tel: (778)968-1176 AVRICORE HEALTH INC. AMENDED NOTICE OF MEETING April 15, 2024 To: All Canadian Securities Regulatory Authorities Re: Avricore Health Inc. (the Company) Annual Gen...
Date: April 15, 2024 Jurisdictions: Alberta, British Columbia
MOSAM CAPITAL CORP ________________________________________________________________________ Suite 1120 - 789 West Pender Street, Vancouver, BC V6C 1H2 Tel: (778)968-1176 AVRICORE HEALTH INC. NOTICE OF MEETING April 15, 2024 To: All Canadian Securities Regulatory Authorities Re: Avricore Health Inc. (the Company) Annual General & S...
Date: April 4, 2024 Jurisdictions: Alberta, British Columbia
AVC2024-04-04HT SignsMoreRexallAgmt-Final HEALTHTAB SIGNS AGREEMENT FOR MORE REXALL PHARMACY LOCATIONS VANCOUVER, BC (GLOBE NEWSWIRE) April 4, 2024 Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (Avricore Health or the Company) is pleased to announce further expansion of HealthTab with Rexall Pharmacy Group ULC (Rexall). The Companie...
Date: November 30, 2023 Jurisdictions: Alberta, British Columbia
AVCR Corp Update_Q3 2023_final AVRICORE HEALTH CORPORATE UPDATE COMPANY DEMONSTRATES STRONG GROWTH VANCOUVER, BRITISH COLUMBIA November 30, 2023 AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or AVCR) reports on its third quarter results which demonstrate significant growth in pharmacy locations offering HealthTab driving strong revenue gro...